Login / Signup

Effectiveness and Safety of Antiobesity Medications in Patients With Obesity and Inflammatory Bowel Disease.

Jonathan T PhamWissam GhusnAndres AcostaEdward V LoftusAmanda M Johnson
Published in: The American journal of gastroenterology (2023)
AOM use in patients with IBD demonstrated similar effectiveness and safety when compared with that observed in the non-IBD population.
Keyphrases
  • ulcerative colitis
  • insulin resistance
  • metabolic syndrome
  • weight loss
  • type diabetes
  • weight gain
  • high fat diet induced
  • adipose tissue